Potential role of epicardial adipose tissue as a biomarker of anthracycline cardiotoxicity.

Caterina Beatrice MontiSimone SchiaffinoMaria Del Mar Galimberti OrtizDavide CapraMoreno ZanardoElena De BenedictisAlberto Gianluigi LuporiniPietro SpagnoloFrancesco SecchiFrancesco Sardanelli

Published in: Insights into imaging (2021)

EAT density appears to be influenced by anthracycline treatment for BC, well known for its cardiotoxicity, shifting towards lower values indicative of a less active metabolism.

Keyphrases

adipose tissue
insulin resistance
metabolic syndrome
type diabetes
replacement therapy
combination therapy